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Abstract
Purpose of Review The goal of this paper is to examine how reward processing might help us understand the symptom of
anhedonia.
Recent Findings There are extensive reviews exploring the relationship between responses to rewarding stimuli and depression.
These often include a discussion on anhedonia and how this might be underpinned in particular by dysfunctional reward
processing. However, there is no specific consensus on whether studies to date have adequately examined the various sub-
components of reward processing or how these might relate in turn to various aspects of anhedonia symptoms.
Summary The approach to understanding the symptom of anhedonia should be to examine all the sub-components of reward
processing at the subjective and objective behavioural and neural levels, with well-validated tasks that can be replicated.
Investigating real-life experiences of anhedonia and how these might be predicted by objective lab measures is also needed in
future research.
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Introduction
Depression is defined as a negative emotional state that affects
daily life, ranging from unhappiness and displeasure to ex-
treme sadness and pessimism. In accordance with the
Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) criteria, the diagnosis of depression necessitates five
or more symptoms within a 2-week period [1]. Anhedonia is
the loss of interest and pleasure during depression and is one
of the two main diagnostic criteria alongside low mood [1].
Even though anhedonia is one of the most important compo-
nents of depression, the behavioural and neurobiological basis
of anhedonia is not completely understood [2•, 3]. In this
respect, the main purpose of this review is to discuss anhedo-
nia in relation to reward processing as studies on the neurobi-
ology of depression [4, 5] suggest that anhedonia is related to
dysfunction in the brain’s reward pathways [6] which in turn,
therefore, may be a potential target for treatment development.
Why Is It Important to Understand
the Symptom of Anhedonia Better?
The term anhedonia was first used in 1896 to describe reduced
hedonic capacity by Théodule-Armand Ribot [7]. Although
historically anhedonia has been mainly described as a ‘loss of
pleasure’, studies reveal other components such as reduced
desire, expectation, motivation, and enjoyment of reward
[8•]. Further, even though anhedonia is frequently considered
as a specific symptom for depression [2•, 7], it is also a com-
mon symptom of many neuropsychological disorders [9•],
such as schizophrenia [10], Parkinson’s disease [11], and sub-
stance abuse [12]. In a recent meta-analysis [13], it has been
emphasized that there is a strong relationship between anhe-
donia and suicidal thoughts, and studies suggest anhedonia
increases the risk of suicide [14•, 15, 16]. Furthermore, in
relation to treatment, anhedonia is the strongest predictor,
among all depressive symptoms, of increased time to remis-
sion [17] and reduced response to serotonergic treatment [8•].
Therefore, it is imperative to increase our understanding of
anhedonia so that we can not only alleviate depression
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symptoms and prevent relapse but also possibly help reduce
suicide risk.
How Might Understanding Reward Illuminate
the Symptom of Anhedonia?
There are many theories as to what might cause anhedonia,
such as stress [18, 19], genetic variations [20••], and dysfunc-
tion in brain activity [21, 22]. The brain’s response to reward
during depression is of interest in relation to understanding the
causes of anhedonia [23] as it is thought that anhedonia comes
about by dysfunctional reward mechanisms in the brain [24].
Seeking out reward is vital for human survival, and eating,
drinking, and mating are basic physiological needs [25, 26].
However, reward processing involves more than one neuro-
psychological component such as ‘liking’, defined as a hedon-
ic sensation; there is also ‘wanting’, thought of as the motiva-
tion to get a reward, and there is also ‘learning’ how we learn
and make decisions to get rewards. Each of these components
plays an important adaptive role in initiating, maintaining, and
modifying our behaviour [27]. The neurobiology of reward
has already been widely reviewed [28]; in summary, neuroim-
aging and neural recording studies have found that rewards
ranging from sweet taste to intravenous cocaine, winning
money, or a smiling face activate many brain structures, in-
cluding orbitofrontal cortex, anterior cingulate and insula, and
subcortical structures such as nucleus accumbens, ventral
pallidum, ventral tegmentum, and mesolimbic dopamine pro-
jections and the amygdala [29–37]. Thus, neural differences in
these systems may be underpinned by variations in dopamine,
and reviews suggest that anhedonia might be improved by
modulating changes in the mesolimbic dopamine system,
which in turn could increase motivation and reactivity to re-
ward [38]. However, dopamine is not the only neurotransmit-
ter involved in reward and pleasure and rather the opioid,
endocannabinoid, and GABA-benzodiazepine neurotransmit-
ter systems are important for generating pleasurable reactions
[3, 4, 39]. As the symptom of anhedonia itself is also multi-
dimensional with various components that each might be con-
tributing to various aspects of the experience, more work is
needed on a detailed examination of the sub-components of
reward processing in relation to anhedonia and brain function.
Whether it is the desire/expectation for reward or the effort to
reach reward or the consummatory response upon receiving a
reward that is the main dysfunction during anhedonia, is not
yet clear [8•, 40, 41••].
It is suggested that stress can disrupt reward processing
[19], and preclinical work shows that physical stress (e.g. foot
shock) decreases consummatory behaviour in rats (decreased
saccharine consumption) [42] and exploratory behaviour [43,
44]. Similarly, acute social stress by means of social defeat in
rats leads to a decrease in reward-seeking behaviour [45]. In
humans, studies have found that an interaction between recent
life stress and ventral striatal (VS) reactivity predicted self-
reported positive affect (PA), such that higher levels of life
stress were associated with lower PA for participants with
relatively low, but not for those with high, VS reactivity.
Interestingly, this work suggests that even in the face of stress,
those with high VS activity may be protected against vulner-
ability to low positive mood precipitated by stressful life
events [46]. Furthermore, Corral-Frias and colleagues [47]
showed that individual differences in neural responses to re-
ward may confer vulnerability to stress-related psychopathol-
ogy. They found that as activation in the VS of individuals
exposed to early life stress (ELS) decreased, the risk for anhe-
donia increased [47]. However, the authors point out that more
work needs to be done to elucidate the relationship between
stress and anhedonia in more detail; for example, it is not
known which types of stress lead to changes in motivation
and reward processing at the molecular and neural levels
[19]. Further studies in humans have found that ELS is asso-
ciated with reward dysfunction, as evidenced by blunted acti-
vation during both reward anticipation in the dorsal striatum
[48, 49] and reward receipt in the ventral striatum [50–52].
Studies have also found that the stress of active military ser-
vice, for example, was related to reduced VS activation during
reward receipt [53] while the stress of a physical cold pressor
has been found to decrease activation to monetary reward in
the dorsal striatum and orbitofrontal cortex in healthy adults
[54]. In an effort to examine patterns of reward function before
and after acute stress, a study by Kumar and colleagues
showed reduced activation in the putamen and caudate during
reward receipt following stress relative to no stress, suggesting
that stress can elicit anhedonic-like activation patterns [55].
Taken together, most studies to date have assessed reward
processing in adults but have not always clearly differentiated
the effects of stress on the sub-components of reward process-
ing. Further, it is important for future work to investigate how
stress and reward processing interact in young people at in-
creased risk of depression, to identify risk factors early that
might be targets for treatment.
Family and twin studies have been used to examine genetic
links with symptoms such as anhedonia [56, 57]. For instance,
Liu and colleagues [56] compared the reward sensitivity of a
group of healthy individuals with no family history of depres-
sion and another group of first-degree relatives of depressed
patients. Compared with the control group, relatives of pa-
tients with major depression who themselves had sub-
clinical depressive symptoms displayed a blunted reward bias
which was associated with anhedonia. Relatives without
symptoms displayed largely intact motivational processing
on both self-report and experimental measures [29]. In another
study examining twins, responses to an objective behavioural
measure of hedonic capacity (reward responsiveness), it was
found that hedonic capacity and perceived stress are indeed
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heritable with substantial shared additive genetic contributions
[30]. The authors also pointed out that replications in larger
samples are needed. Accumulating research suggests that ge-
netic differences conferring relatively increased subcortical
DA or reduced cortical DA signalling (via either receptor
availability or synaptic clearance) are associated with en-
hanced reward-related neural activation and behaviour [58].
This supports the notion that anhedonia might therefore have a
genetic component. Yet most research on the genetics of re-
ward processing have yet to establish how the various sub-
components (anticipation vs motivation vs consummation) of
reward processing might confer genetic risk [58]. Therefore,
more work needs to be done on how to examine if one sub-
component or a combination of them confers risk differently,
in different people. Taken together, it is possible that anhedo-
nia might be precipitated by various factors such as stressful
life events, genetic variations, and/or neural dysfunction.
Knowing more about the mechanisms underpinning anhedo-
nia could help us detect early signs and thus help us develop
preventative strategies and improved treatments.
The Link Between Anhedonia and Reward
Processing in Depression
To date, the neurobiology of reward deficits in depression
have been well documented in adults [59, 60] and more re-
cently in adolescents [61–64]. In summary, studies report
mostly decreased responses to the anticipation and outcome
of reward (money) in regions like the ventral striatum, cau-
date, the dorsolateral and medial prefrontal cortex (PFC),
orbitofrontal cortex (OFC), anterior cingulate cortex (ACC),
and amygdala [61, 65]. Striatal regions are often reported as
negatively correlating with anhedonia and subjective positive
affect in depression [9•, 66]. Yet as mentioned above, the sub-
components of reward processing are not always explicitly
examined in studies of reward and it has been argued that
using the receipt of monetary rewards in tasks cannot capture
adequately consummatory hedonic responses as the money is
not actually received during the study (on each trial) and mon-
ey is itself a secondary reinforcer [6, 41••]. In an attempt to
examine the various sub-components of reward processing in
relation to anhedonia, we have employed a task that uses both
primary and secondary reinforcers. Our tasks also separate out
anticipation from motivation using effort and anticipation
from consummation using taste. We recently found using this
that adolescents with depression symptoms have blunted neu-
ral responses during the anticipation, effort, and consumma-
tion of rewarding and aversive stimuli [67, 68]. This work is of
interest as it shows how anhedonia is related to all the sub-
components of reward processing but also to blunted aversion
processing. This data is novel and interesting as it provides
evidence for motivational deficits in those at increased risk of
clinical depression and that motivational deficits need not be
just to reward but could affect how one acts to avoid aversion.
As mentioned above, learning about rewards is also impor-
tant if we are to optimally direct our behaviour towards
gaining rewards. Previous research suggests that anhedonia
and depression are related to impaired reward learning, on
both the behavioural and the neural levels [38, 69].
Computational models have been used to examine learning
about rewards and specifically used to examine how predic-
tion error signalling is related to reward learning deficits in
depression. A prediction error (PE), in simple terms, is calcu-
lated by subtracting the prediction value (how strongly a given
cue is associated with positive or negative outcomes) from the
outcome value. Finally, the prediction value is updated by
adding the prediction error, multiplied by a learning rate.
Studies find that medicated depressed subjects have reduced
reward PE encoding in the ventral and dorsal striatum, the
midbrain, and the hippocampus [70]. Further studies find that
self-reported depression scores in unmedicated individuals
negatively correlate with decreased reward PE encoding in
the ventral striatum [71]. Interestingly, not all studies measure
anhedonia and of those that do, the sub-components are not
always measured, e.g. anhedonia scores, using the Snaith
Hamilton Pleasure Scale (SHAPS), in unmedicated depressed
individuals were found to negatively correlate with reward PE
signals in the medial OFC [72]. However, the SHAPS mea-
sures only hedonic tone and not anticipatory of motivational
aspects of anhedonia. Further, most studies to date have not
related their findings to real-life experiences of anhedonia. In
an attempt to address this, we recently found that adults with
high depression symptoms compared to those with low symp-
toms spend higher amounts of time in negatively perceived
real-life situations and that this was predicted by lower learn-
ing rates in our social reward learning task (using Facebook
likes as a reward) using computational modelling [73••].
These findings support the idea that deficits in learning may
negatively affect the quality of everyday life experiences and
that impaired ability to use reward feedback to appropriately
update future actions may lead to suboptimal real-life experi-
ences. It therefore would be of interest in future work to ex-
amine how we can use objective measures of the various sub-
components of reward processing, i.e. reward learning, reward
anticipation, motivation, and consummation, to predict real-
life rewarding interactions and therefore risk of anhedonia in
young people. As it has been suggested that anhedonia may be
a possible biomarker for depression (57) as it seems to predate
depression and persist into recovery [74], examining young
people before they have clinical depression and how they
respond to reward in a dimensional fashion across the spec-
trum would be beneficial [24, 67].
Further understanding of the neural functions underlying
reward could then allow the testing of the effects of antide-
pressant treatments on reward function in line with
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anhedonia’s potential as a biomarker tool [75]. In this context,
a recent qualitative analysis by Cao and colleagues [76] ex-
amined the therapeutic efficacy of pharmacological treatments
on measures of anhedonia in adults with MDD. They reported
that a significant number of antidepressants do have beneficial
effects on anhedonic symptoms as well as depressive symp-
toms [5, 76]. Interestingly, the authors also state that therapies
targeting melatonergic receptors and circadian rhythm imbal-
ances are more direct targets for treating anhedonia while
drugs like ketamine may be faster acting on anhedonia due
to their direct effect on mitochondrial energy metabolism. The
authors also point out that future studies should aim to evalu-
ate the comparative efficacy of different pharmacological
agents on measures of anhedonia and that measures of func-
tion and quality of life should also be investigated.
Although perhaps less often studied, there is also growing
evidence for the effects of psychological treatments on anhe-
donia. Behavioural activation (BA), for example, works by
increasing engagement with reinforcers within the environ-
ment and overcoming avoidance [5]. Recent promising find-
ings in adults show that greater pre-treatment anhedonia se-
verity in a monetary reward processing task [77] and de-
creased neural functional connectivity, in a positive emotion
upregulation task [78], are predictive of response to BA treat-
ment. Further, BA is thought to be more cost effective and
more acceptable to young people who are depressed than oth-
er psychotherapies [79], but it is still not effective for every-
one. Therefore, increased understanding of reward processing
and how it underpins the symptom of anhedonia could also
allow the development of more effective psychological treat-
ments for depression.
Conclusion
Studies to date have elucidated the reward system in both
animal and human neural systems and behaviours. Reviews
have described the role of the reward system in depression and
those at risk of depression. However, there is still not a clear
understanding of how the sub-components of reward process-
ing might underpin the symptom of anhedonia in depression
or in those at risk of depression. Further, it is still not clear how
the everyday experiences of anhedonia relate back to the ob-
jective measures of reward processing used in lab experi-
ments. Therefore, going forward, more needs to be done to
map the subjective experience of anhedonia with the behav-
ioural and neural measures of reward processing if we are to
find new targets for intervention and treatment strategies.
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